US EditionFirst UK User Describes Experience with Neuralink Brain Chip
Neuralink's clinical trials now include 21 participants across four countries, aiming to restore autonomy for people with severe paralysis using brain implants.
- Sebastian Gomez-Pena, volunteer in the first UK trial, showed he can control a laptop cursor using the Neuralink chip linked to 1,024 electrodes implanted at University College London Hospital by Neuralink's R1 surgical robot.
- It's taken Neuralink nearly 20 years to develop its chip, electrode, robot and AI tools, with the mission to restore autonomy for those with unmet medical needs while larger clinical trials are required.
- Nerve signals travel via electrode threads around 10-times thinner than a human hair to the chip, with 4mm electrode insertion depth in the hand-movement brain area, while AI decoding software `learns` to interpret signals.
- One early UK user described the impact as life-changing, saying `It is a massive change in your life where you can suddenly no longer move any of your limbs`, while Neuralink has not published results in peer-reviewed scientific journals and declined interviews.
- Neuralink plans include the Blindsight augment to restore vision, while Elon Musk said a next-generation Neuralink implant with three times current capability is expected later this year.
15 Articles
15 Articles
There has been an increase in the number of test subjects who have received the chip, which will be used to help people with paralysis.
One of the first users of the Neuralink brain chip in the UK says using the technology "feels magical." The device, developed by Elon Musk's company, allows people with severe paralysis to control a computer with just their thoughts.
Elon Musk Announces Timeline For Next-Gen Neuralink Implant With 3X Capability — 21 People Already Enrolled Worldwide
Neuralink has grown its human trials to 21 participants worldwide as Elon Musk confirms a next-generation brain implant with three times the current capabilities is set to debut later this year. Neuralink Expands Human Trials On Wednesday, Musk's brain-implant company said that it now has 21 participants enrolled in clinical trials across the globe. This marks a notable increase from the 12 people reported using the implants in September to cont…
Elon Musk’s Neuralink Reaches 21 Global Trial Participants; Billionaire Announces Next-Gen ‘Telepathy’ Implant and Vision-Restoring ‘Blindsight’ Launch | 🔬 LatestLY
Neuralink has enrolled 21 participants worldwide in its human brain-chip trials, up from 12 in 2024. Elon Musk said the Telepathy implant enables users with paralysis to control devices using thoughts. The trials focus on spinal injuries and ALS, with zero serious adverse events reported so far. 🔬 Elon Musk’s Neuralink Reaches 21 Global Trial Participants; Billionaire Announces Next-Gen ‘Telepathy’ Implant and Vision-Restoring ‘Blindsight’ Laun…
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
